Clinuvel Pharmaceuticals Limited (ADR) share price logo

Clinuvel Pharmaceuticals Limited (ADR)

NASDAQ: CUVL

$7.02

-0.38

(-5.14%)

as on

Clinuvel Pharmaceuticals Limited (ADR) Stock Performance

as on July 22, 2026 at 6:59 am IST

  • Day's High

    $7.02
    $7.24

    3.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Clinuvel Pharmaceuticals Limited (ADR) share price movements today

Previous Close
$7.40
Open
$7.21
Volume
226.8K
Day's Low - High
$7.02 - $7.24

Clinuvel Pharmaceuticals Limited (ADR) Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Clinuvel Pharmaceuticals Limited (ADR) Stock Fundamentals & Key Indicators

Check Clinuvel Pharmaceuticals Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Clinuvel Pharmaceuticals Limited (ADR) stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Clinuvel Pharmaceuticals Limited (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$-NANA0.00%NA

About Clinuvel Pharmaceuticals Limited (ADR)


OrganisationClinuvel Pharmaceuticals Limited (ADR)
Headquarters535 Bourke Street, Melbourne, VIC, Australia, 3000
IndustryMiscellaneous
CEODr. Philippe Jacques Wolgen M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Clinuvel Pharmaceuticals Limited (ADR)

Name

Title

Mr. Malcolm Bull

Head of Australian Operations & Investor Relations

Dr. Linda Teng

Director of North American Operations

Mr. Peter Vaughan

Chief Financial Officer

Mr. Lachlan Hay

Chief Operations Officer

Dr. Dennis J. Wright BPharm, M.Sc., Ph.D.

Chief Scientific Officer

Dr. Emilie Rodenburger

Director of Global Clinical Affairs

Dr. Philippe Jacques Wolgen M.B.A., M.D.

CEO, MD & Director

Dr. Azza Hamila

Head of Quality Assurance & Drug Safety

Ms. Claire Newstead-Sinclair C.A.

Company Secretary

FAQs

What is Clinuvel Pharmaceuticals Limited (ADR) share price today?

Clinuvel Pharmaceuticals Limited (ADR) share price today is $7.02 as on at the close of the market. Clinuvel Pharmaceuticals Limited (ADR) share today touched a day high of $7.24 and a low of $7.02.

What is the 52 week high and 52 week low for Clinuvel Pharmaceuticals Limited (ADR) share?

Clinuvel Pharmaceuticals Limited (ADR) share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Clinuvel Pharmaceuticals Limited (ADR) stock price today i.e. is closed at $7.02,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Clinuvel Pharmaceuticals Limited (ADR) Stock (CUVL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Clinuvel Pharmaceuticals Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clinuvel Pharmaceuticals Limited (ADR) Shares that will get you 0.2137 shares as per Clinuvel Pharmaceuticals Limited (ADR) share price of $7.02 per share as on July 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Clinuvel Pharmaceuticals Limited (ADR) Stock (CUVL) from India?

Indian investors can start investing in Clinuvel Pharmaceuticals Limited (ADR) (CUVL) shares with as little as ₹96.235 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.35 in Clinuvel Pharmaceuticals Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Clinuvel Pharmaceuticals Limited (ADR) share’s latest price of $7.02 as on July 22, 2026 at 1:29 am IST, you will get 1.4245 shares of Clinuvel Pharmaceuticals Limited (ADR). Learn more about fractional shares .